These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4361661)

  • 1. Hypermyoinositolemic polyneuropathy in rats. A possible mechanism for uremic polyneuropathy.
    DeJesus PV; Clements RS; Winegrad AI
    J Neurol Sci; 1974 Mar; 21(3):237-49. PubMed ID: 4361661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic polyneuropathy: clinico-electroneurographic study of 36 cases].
    Werneck LC; Mulinari AS; Laffite A; Kesikowski LB
    Arq Neuropsiquiatr; 1979 Dec; 37(4):356-72. PubMed ID: 93959
    [No Abstract]   [Full Text] [Related]  

  • 3. Nerve conduction times in uremia.
    Savazzi GM
    Int J Artif Organs; 1981 Sep; 4(5):211-2. PubMed ID: 6274807
    [No Abstract]   [Full Text] [Related]  

  • 4. Nerve excitability in chronic renal disease.
    McQuillen MP; Procopis PG; Luke RG
    Trans Am Soc Artif Intern Organs; 1973; 19():337-9. PubMed ID: 4352990
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of hemodialytic treatment on uremic polyneuropathy. A clinical and electrophysiological follow-up study.
    Caccia MR; Mangili A; Mecca G; Ubiali E; Zanoni P
    J Neurol; 1977 Dec; 217(2):123-31. PubMed ID: 75258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.
    Goldstein DA; Chui LA; Massry SG
    J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy in B6C3F1 mice and SD rats induced by chronic intermittent insulin hypoglycemia.
    Tabata H
    Drug Chem Toxicol; 2000 Aug; 23(3):485-96. PubMed ID: 10959549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic polyneuropathy: and motor nerve conduction velocities.
    Versaci AA; Olsen KJ; McMain PB; Nakamoto S; Kolff WJ
    Trans Am Soc Artif Intern Organs; 1964; 10():328-31. PubMed ID: 4292699
    [No Abstract]   [Full Text] [Related]  

  • 9. Excitability changes reveal decreased sodium permeability in neuropathy.
    Brismar T; Tegnér R
    Exp Neurol; 1985 Jan; 87(1):177-80. PubMed ID: 2981698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
    Eisen AA; Woods JF; Sherwin AL
    Neurology; 1974 May; 24(5):411-7. PubMed ID: 4363815
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysiologic and morphometric studies on the peripheral nerves of rats intoxicated with methylmercury compound (author's transl)].
    Kumamoto T
    Rinsho Shinkeigaku; 1980 Jan; 20(1):31-9. PubMed ID: 6245826
    [No Abstract]   [Full Text] [Related]  

  • 12. [The F-wave in uremic neuropathy].
    Fierro B; Modica A; D'Arpa A; Santangelo R; Raimondo D
    Acta Neurol (Napoli); 1986 Aug; 8(4):404-11. PubMed ID: 3022562
    [No Abstract]   [Full Text] [Related]  

  • 13. Uremic neuropathy: clinical features and new pathophysiological insights.
    Krishnan AV; Kiernan MC
    Muscle Nerve; 2007 Mar; 35(3):273-90. PubMed ID: 17195171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in motor nerve conduction velocity in normal and uremic patients.
    Kominami N; Tyler HR; Hampers CL; Merrill JP
    Arch Intern Med; 1971 Aug; 128(2):235-239. PubMed ID: 4327548
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neural conduction velocity in uremic neuropathy].
    Parisen Toldin P; Pisani E; D'Andrea G; Lagreca G; Ferro Milone F
    Riv Neurobiol; 1978; 24(1-2):5-12. PubMed ID: 231817
    [No Abstract]   [Full Text] [Related]  

  • 16. Raised plasma-myoinositol levels in uraemia and experimental neuropathy.
    Clements RS; DeJesus PV; Winegrad AI
    Lancet; 1973 May; 1(7813):1137-41. PubMed ID: 4123536
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects of uraemic polyneuropathy.
    Jennekens FG; Mees EJ; Most van Spijk D van
    Nephron; 1971; 8(5):414-26. PubMed ID: 4332580
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of uraemic polyneuropathy.
    Jennekens FG; Mees EJ; van de Most van Spijk D
    Nephron; 1971; 8(5):414-26. PubMed ID: 4331711
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of glomerular filtration rate on uremic polyneuropathy.
    Savazzi GM; Migone L; Cambi V
    Clin Nephrol; 1980 Feb; 13(2):64-72. PubMed ID: 6244910
    [No Abstract]   [Full Text] [Related]  

  • 20. Axoplasmic electrolyte contents measured by X-ray microanalysis in experimental uremic neuropathy.
    Shibahara N; Okada S; Onishi S; Hamada K; Takasaki N; Miyazaki S; Nakagaki I; Sasaki S
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):885-92. PubMed ID: 2174479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.